Skip to content

Zhejiang Jiuzhou Pharmaceutical Co Ltd Sustainability Reports

The company operates as a contract development and manufacturing organization (CDMO) providing custom R&D and manufacturing services for small molecules, peptides, and drug products. It also produces active pharmaceutical ingredients (APIs) and pharmaceutical intermediates.

Sector: Manufacturing

Country: China

Exchange: Shanghai Stock Exchange

FIGI: BBG001TZJ356

1 reports from 2022 to 2022